Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity

• Conditions: Retinopathy of Prematurity

• Registration Number: NCT00339001
• Lead Sponsor: Sheba Medical Center

Brief Summary

To evaluate the possibility that erythropoietin with early iron supplementation may induce retinopathy of prematurity or worsen this disease. In addition risk factors for the development of ROP will be checked.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-04
• Status Verified: 2006-06
• Study First Submitted: 2006-06-19
• Study First Submitted QC: 2006-06-19
• Last Update Submitted: 2006-06-19
• Study First Posted: 2006-06-20
• Last Update Posted: 2006-06-20
• Study Completion: 2006-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

• all premature infants with birth weight of 1250 grams or less

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Neonatal Department, Sheba Medical Center; 🇮🇱 Ramat-Gan, Israel